Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States.

Autor: Lurain K; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address: kathryn.lurain@nih.gov., Zarif TE; Yale University School of Medicine, New Haven, CT., Ramaswami R; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Nassar AH; Yale University School of Medicine, New Haven, CT., Adib E; Brigham and Women's Hospital, Department of Radiation Oncology, Boston, MA., Abdel-Wahab N; MD Anderson Cancer Center, Houston, TX., Chintapally N; Medstar/Georgetown-Washington Hospital Center, Washington, DC., Drolen CE; University of California Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA., Feldman T; John Theurer Cancer Center, Hackensack, NJ., Haykal T; Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC; Ohio State University Comprehensive Cancer Center, Columbus, OH., Nebhan CA; Vanderbilt University Medical Center, Nashville, TN., Kambhampati S; City of Hope Medical Center, Duarte, CA., Li M; Ohio State University Comprehensive Cancer Center, Columbus, OH., Mittra A; Ohio State University Comprehensive Cancer Center, Columbus, OH., Lorentsen M; University of North Carolina, Chapel Hill, NC., Kim C; Medstar Georgetown University Hospital, Washington, DC., Drakaki A; University of California Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA., Morse M; Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC., Johnson DB; Vanderbilt University Medical Center, Nashville, TN., Mangla A; University Hospital Seidman Cancer Center, Cleveland, OH., Dittus C; University of North Carolina, Chapel Hill, NC., Ravi P; Dana-Farber Cancer Institute, Boston, MA., Baiocchi RA; Ohio State University Comprehensive Cancer Center, Columbus, OH., Chiao EY; MD Anderson Cancer Center, Houston, TX., Rubinstein PG; John Stroger Cook County Hospital, Chicago, IL., Yellapragada SV; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine & Michael E. DeBakey VA Medical Center, Houston, TX., LaCasce AS; Dana-Farber Cancer Institute, Boston, MA., Sonpavde GP; Dana-Farber Cancer Institute, Boston, MA., Naqash AR; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK., Herrera AF; City of Hope Medical Center, Duarte, CA.

Publikováno v: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Aug; Vol. 24 (8), pp. 523-530. Date of Electronic Publication: 2024 Apr 05.

Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 (HDAC3) Stabilization and Chromatin Condensation.

Autor: Maneix L; Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA.; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Cell and Gene Therapy Program at the Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Iakova P; Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA.; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Cell and Gene Therapy Program at the Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Moree SE; Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA.; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Cell and Gene Therapy Program at the Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Hsu JI; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Cell and Gene Therapy Program at the Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Mistry RM; Integrated Microscopy Core and GCC Center for Advanced Microscopy and Image Informatics, Baylor College of Medicine, Houston, TX 77030, USA., Stossi F; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Integrated Microscopy Core and GCC Center for Advanced Microscopy and Image Informatics, Baylor College of Medicine, Houston, TX 77030, USA., Lulla P; Cell and Gene Therapy Program at the Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Hematology-Oncology, Baylor College of Medicine, Houston, TX 77030, USA., Sun Z; Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA., Sahin E; Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA., Yellapragada SV; Department of Hematology-Oncology, Baylor College of Medicine, Houston, TX 77030, USA.; Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA., Catic A; Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA.; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Cell and Gene Therapy Program at the Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.; Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA.

Publikováno v: Cancer research communications [Cancer Res Commun] 2022 Dec; Vol. 2 (12), pp. 1693-1710. Date of Electronic Publication: 2022 Dec 27.

Lack of differential impact of del17p on survival in African Americans compared with White patients with multiple myeloma: a VA study.

Autor: Fillmore NR; VA Boston Healthcare System, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA., Cirstea D; Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA., Munjuluri A; VA Boston Healthcare System, Boston, MA.; Dana-Farber Cancer Institute, Boston, MA., Yameen H; St. Joseph Hospital, Nashua, NH., Yellapragada SV; Michael E. DeBakey VA Medical Center, Houston, TX.; Department of Medicine, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX; and., Do NV; VA Boston Healthcare System, Boston, MA.; Boston University School of Medicine, Boston, MA., Brophy MT; VA Boston Healthcare System, Boston, MA.; Boston University School of Medicine, Boston, MA., Szalat RE; VA Boston Healthcare System, Boston, MA.; Boston University School of Medicine, Boston, MA., Munshi NC; VA Boston Healthcare System, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.

Publikováno v: Blood advances [Blood Adv] 2021 Sep 28; Vol. 5 (18), pp. 3511-3514.

The Mitochondrial Protease LonP1 Promotes Proteasome Inhibitor Resistance in Multiple Myeloma.

Autor: Maneix L; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA.; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA., Sweeney MA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA.; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA., Lee S; Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA., Iakova P; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA.; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA., Moree SE; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA.; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA., Sahin E; Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA., Lulla P; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Yellapragada SV; Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.; Michael E. DeBakey VA Medical Center, Houston, TX 77030, USA., Tsai FTF; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA., Catic A; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.; Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA.; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA.; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.; Michael E. DeBakey VA Medical Center, Houston, TX 77030, USA.

Publikováno v: Cancers [Cancers (Basel)] 2021 Feb 17; Vol. 13 (4). Date of Electronic Publication: 2021 Feb 17.

Vitamin D deficiency predicts for poor overall survival in white but not African American patients with multiple myeloma.

Autor: Yellapragada SV; Michael E. DeBakey VA Medical Center, Houston, TX.; Department of Medicine, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX., Fillmore NR; VA Boston Healthcare System, Boston, MA.; Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA., Frolov A; Michael E. DeBakey VA Medical Center, Houston, TX.; Department of Medicine, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX., Zhou Y; Michael E. DeBakey VA Medical Center, Houston, TX.; Department of Medicine, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX., Dev P; University of Texas Southwestern Medical Center, Dallas, TX., Yameen H; St. Joseph Hospital, Nashua, NH; and., Ifeorah C; Michael E. DeBakey VA Medical Center, Houston, TX.; Department of Medicine, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX., Do NV; VA Boston Healthcare System, Boston, MA.; Section of General Internal Medicine and., Brophy MT; VA Boston Healthcare System, Boston, MA.; Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA., Munshi NC; VA Boston Healthcare System, Boston, MA.; Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.

Publikováno v: Blood advances [Blood Adv] 2020 Apr 28; Vol. 4 (8), pp. 1643-1646.